Charles River Laboratories Receivables 2010-2024 | CRL

Charles River Laboratories receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Charles River Laboratories receivables for the quarter ending September 30, 2024 were $0.754B, a 5.64% decline year-over-year.
  • Charles River Laboratories receivables for 2023 were $0.78B, a 3.72% increase from 2022.
  • Charles River Laboratories receivables for 2022 were $0.752B, a 17.03% increase from 2021.
  • Charles River Laboratories receivables for 2021 were $0.643B, a 4.07% increase from 2020.
Charles River Laboratories Annual Receivables
(Millions of US $)
2023 $780
2022 $752
2021 $643
2020 $618
2019 $514
2018 $472
2017 $430
2016 $364
2015 $270
2014 $258
2013 $221
2012 $203
2011 $185
2010 $193
2009 $190
Charles River Laboratories Quarterly Receivables
(Millions of US $)
2024-09-30 $754
2024-06-30 $762
2024-03-31 $787
2023-12-31 $780
2023-09-30 $799
2023-06-30 $801
2023-03-31 $788
2022-12-31 $752
2022-09-30 $771
2022-06-30 $748
2022-03-31 $698
2021-12-31 $643
2021-09-30 $660
2021-06-30 $644
2021-03-31 $611
2020-12-31 $618
2020-09-30 $572
2020-06-30 $533
2020-03-31 $542
2019-12-31 $514
2019-09-30 $524
2019-06-30 $545
2019-03-31 $496
2018-12-31 $472
2018-09-30 $487
2018-06-30 $479
2018-03-31 $440
2017-12-31 $430
2017-09-30 $422
2017-06-30 $399
2017-03-31 $384
2016-12-31 $364
2016-09-30 $360
2016-06-30 $346
2016-03-31 $287
2015-12-31 $270
2015-09-30 $289
2015-06-30 $277
2015-03-31 $265
2014-12-31 $258
2014-09-30 $275
2014-06-30 $275
2014-03-31 $240
2013-12-31 $221
2013-09-30 $224
2013-06-30 $224
2013-03-31 $214
2012-12-31 $203
2012-09-30 $216
2012-06-30 $208
2012-03-31 $206
2011-12-31 $185
2011-09-30 $202
2011-06-30 $212
2011-03-31 $215
2010-12-31 $193
2010-09-30 $217
2010-06-30 $219
2010-03-31 $220
2009-12-31 $190
2009-09-30 $213
2009-06-30 $210
2009-03-31 $211
Sector Industry Market Cap Revenue
Medical Medical Services $11.014B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.015B 12.16
Cencora (COR) United States $48.948B 18.05
DiDi Global (DIDIY) China $23.622B 0.00
ICON (ICLR) Ireland $17.731B 15.79
Natera (NTRA) United States $16.587B 0.00
Viatris (VTRS) United States $15.469B 4.76
Avantor (AVTR) United States $15.375B 23.05
Revvity (RVTY) United States $14.905B 25.89
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.590B 0.00
Solventum (SOLV) United States $12.509B 0.00
Medpace Holdings (MEDP) United States $11.276B 31.77
Doximity (DOCS) United States $10.815B 64.01
HealthEquity (HQY) United States $8.629B 46.83
Sonic Healthcare (SKHHY) Australia $8.542B 0.00
Bausch + Lomb (BLCO) Canada $7.043B 32.79
Life Times (LTH) United States $5.170B 34.22
Sotera Health (SHC) United States $4.557B 24.38
Organon (OGN) United States $4.131B 4.17
Surgery Partners (SGRY) United States $3.859B 42.76
BrightSpring Health Services (BTSG) United States $3.408B 72.48
PACS (PACS) United States $3.251B 0.00
Alignment Healthcare (ALHC) United States $2.620B 0.00
Concentras Parent (CON) United States $2.500B 0.00
Ardent Health Partners (ARDT) United States $2.337B 0.00
Premier (PINC) United States $2.292B 11.44
GeneDx Holdings (WGS) United States $2.137B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.589B 0.00
Progyny (PGNY) United States $1.499B 26.37
Pediatrix Medical (MD) United States $1.353B 13.24
Establishment Labs Holdings (ESTA) $1.292B 0.00
CareDx (CDNA) United States $1.268B 0.00
AMN Healthcare Services Inc (AMN) United States $1.104B 7.49
Embecta (EMBC) United States $0.897B 5.98
InnovAge Holding (INNV) United States $0.813B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.757B 0.00
SBC Medicals (SBC) United States $0.706B 0.00
Auna S.A (AUNA) Luxembourg $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.469B 0.00
DocGo (DCGO) United States $0.409B 15.38
Enhabit (EHAB) United States $0.397B 34.30
COMPASS Pathways (CMPS) United Kingdom $0.373B 0.00
LifeMD (LFMD) United States $0.252B 0.00
Sera Prognostics (SERA) United States $0.225B 0.00
ModivCare (MODV) United States $0.221B 12.05
Beauty Health (SKIN) United States $0.202B 0.00
Biodesix (BDSX) United States $0.199B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.129B 0.00
So-Young (SY) China $0.089B 21.63
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.055B 0.00
OncoCyte (OCX) United States $0.048B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.036B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00